<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-28T02:55:30Z</responseDate><request verb="GetRecord" identifier="oai:kostu-rdlopen.rawdatalibrary.net:kostu/10228" metadataPrefix="oai_dc">https://kostu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:kostu-rdlopen.rawdatalibrary.net:kostu/10228</identifier><datestamp>2026-10-27T23:53:12Z</datestamp><setSpec>openaire</setSpec><setSpec>com_kostu_10000</setSpec><setSpec>col_kostu_10001</setSpec><setSpec>com_kostu_10010</setSpec><setSpec>col_kostu_10063</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Development of Fluorimetric Method for Controlled Drug Release From Vinyl Propionate-co-Maleic Anhydride Polymer Modified With Paracetamol</dc:title><dc:creator>Memis, Yilmaz</dc:creator><dc:creator>Gunduz, S. Beniz</dc:creator><dc:creator>Altuner, Elif Esra</dc:creator><dc:creator>Tatli, Havva Nur</dc:creator><dc:creator>Ozen, Gurkan</dc:creator><dc:creator>Okudan, Ahmet</dc:creator><dc:creator>Civil, Serife</dc:creator><dc:creator>Dar, Umar Ali</dc:creator><dc:subject>controlled drug release</dc:subject><dc:subject>copolymer</dc:subject><dc:subject>fluorimetric method</dc:subject><dc:subject>paracetamol</dc:subject><dc:subject>vinyl propionate-maleic anhydride</dc:subject><dc:description>A novel pH-responsive polymeric drug delivery system is developed by covalently binding the active pharmaceutical ingredient paracetamol (PAR) to a synthesized vinyl propionate-co-maleic anhydride (VPR-co-MA) copolymer. The controlled release of PAR from the resulting VPR-co-MA-PAR conjugate was investigated in vitro at various physiological pH values (2.0, 4.5, 7.4, and 9.0) at 37°C over a 6 h-period. A fluorimetric method was utilized to quantify the released PAR, with optimal excitation and emission wavelengths determined to be 330 and 433 nm, respectively. The results demonstrated a distinct pH-dependent release profile. After 6 h, the cumulative drug release was significantly suppressed at acidic gastric pH 2.0 (42.23%), whereas it was substantially higher at neutral and alkaline conditions, reaching 71.29% at pH 7.4 and a maximum of 74.46% at pH 9.0. The pronounced difference in release rates confirms the system's ability to limit premature drug release in the stomach while promoting targeted delivery in the intestinal tract. This VPR-co-MA-PAR conjugate shows significant promise as a carrier for the controlled oral delivery of paracetamol.</dc:description><dc:publisher>John Wiley and Sons Inc</dc:publisher><dc:date>2026</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/kostu/10228</dc:identifier><dc:identifier>https://doi.org/10.1002/slct.73271</dc:identifier><dc:identifier>2365-6549</dc:identifier><dc:language>en</dc:language><dc:relation>ChemistrySelect</dc:relation><dc:rights>info:eu-repo/semantics/closedAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://kostu-rdlopen.rawdatalibrary.net/tr/items/kostu/10228</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>